Diane Wotta

Sr. Director of Global Quality Assurance, Regulatory Affairs and Safety at R&D Systems
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 300 - 400 Employee
    • Sr. Director of Global Quality Assurance, Regulatory Affairs and Safety
      • Sep 2018 - Present

    • Sr. Director of Quality and Regulatory Affairs
      • Aug 2014 - Sep 2018

    • Director, Quality Control
      • Jul 2013 - Aug 2014

      Direct a team of 80 Quality Control professionals. Processes are certified to ISO 9001.

    • Manager, Quality Assurance
      • Jan 2009 - Jun 2013

      Manage a team of 10 Quality professionals. Oversee customer complaints, MRB, CAPA and document control systems. Perform customer audits and write audit responses. Author SDS, SOP, COA and COO. Certified Manager of Quality/Organizational Excellence, ASQ-CME/OE, CMDCAS 13485, ISO 13485, ISO 9001, IATA Dangerous Good Shipping.

    • Manager, Cell Culture Production
      • May 2000 - Dec 2008

      Managed a department of 20 people responsible for the production of approximately 2500 recombinant protein and antibody products. Used both batch and fed-batch techniques to culture mammalian, insect and hybridoma cell lines in both small- and large-scale cultures (1 - 100 liters). Assisted in the design and managed an animal-free E. coli fermentation laboratory which provided cell paste for over 500 products.

    • Scientist, Molecular Biology
      • Jan 1998 - May 2000

      Designed mammalian protein expression vectors for enhancing secreted protein expression; including dual protein expression vectors.

    • Board of Directors
      • 2010 - Jun 2015

  • 3M Pharmaceuticals
    • Greater Minneapolis-St. Paul Area
    • Biochemist
      • 1987 - 1992

      Developed bioassays for asthma drug development high throughput screening (HTS). Techniques included enzyme purification, cell culture, RIA and HPLC. Developed bioassays for asthma drug development high throughput screening (HTS). Techniques included enzyme purification, cell culture, RIA and HPLC.

    • Medical Technologist
      • Aug 1980 - Aug 1987

      Biochemistry, Hematology, Blood Bank and Urinalysis Biochemistry, Hematology, Blood Bank and Urinalysis

Education

  • University of Minnesota
    Ph.D., Pharmacology
    1992 - 1995
  • College of Saint Benedict
    Bachelor of Arts (B.A.), Natural Sciences/Medical Technology

Community

You need to have a working account to view this content. Click here to join now